Contents
Contents
Free laboratory supplies can be kickbacks when a lab uses them to buy testing referrals. A cup, a salary or free office work can cover costs the physician’s practice would otherwise pay itself. The benefit reaches the practice through its supply cabinet or staffing budget, while the laboratory bills for the testing sent its way. If you supply the cups, draw the blood or manage the office, you may know exactly what the laboratory promised and what it expected back. The job description and the job can tell different stories.
Yes. Government laboratory cases describe alleged kickbacks that include free testing supplies and salaries paid for people working in the referring practice. The value can be an expense taken off the practice’s books. The Anti-Kickback Statute reaches benefits offered to induce referrals paid by Medicare, Medicaid and other federal health care programs. Claims knowingly submitted through a kickback arrangement can violate the False Claims Act.
The business makes that exchange attractive. An independent laboratory depends on clinicians to order its tests. The ordering practice holds the patient’s medical record. The laboratory performs the testing and submits the claim. Major laboratories place their own phlebotomists in physician offices, where the blood is drawn before the specimen leaves with the laboratory’s courier.
That connection supplies a business built around recurring volume. Couriers, ordering systems and analyzers need specimens. A free employee or testing supply offered in exchange for referrals ties the practice’s operating costs to the laboratory’s sales. We see the problem in that bargain: the office gets the saving, while the patient’s health program gets the bill.
Free urine cups conditioned on sending specimens for confirmation connect an immediate office benefit to additional laboratory billing. The cup can perform an in-office drug screen as well as hold a specimen for shipment. The practice gets a test result before the outside laboratory does any testing.
A competitor’s complaint concerning Calloway Laboratories described that second function:
In addition to allowing for the collection of urine specimens from patients for clinic laboratory analysis, the “dual use” collection cups also provide an instant “on-site” result for certain drug classifications. These “dual use” collection cups are read on-site, but are also sent to the clinical laboratory for further testing.
Millennium Health, formerly Millennium Laboratories, agreed in October 2015 to pay $256 million across civil and administrative settlements involving alleged unnecessary testing and kickbacks. The Justice Department’s announcement described free drug-test cups allegedly supplied on the express condition that physicians return the specimens for hundreds of dollars’ worth of additional testing.
We see the alleged bargain: a free cup that buys more testing. The government also alleged that Millennium promoted custom profiles that operated as standing orders, causing physicians to order large numbers of tests without assessing each patient’s needs. In that alleged arrangement, the cup brought in the specimen and the order form expanded what Millennium billed from it.
The HHS Office of Inspector General’s laboratory payments alert expressly addressed free or below-market point-of-care urine cups used for billable in-office testing.
When a laboratory phlebotomist performs unpaid work for physician office staff, the practice receives labor at the laboratory’s expense. Taking vital signs, performing nursing duties, doing clerical work or testing for the physician’s own office laboratory are the examples OIG named in its 1994 laboratory fraud alert.
The starting assignment is collecting specimens for the outside laboratory. The important change is the addition of duties the practice would otherwise staff itself.
OIG also addressed the paper defense. A contract restricting the phlebotomist to specimen collection did not remove its concern where the employer failed to monitor the work closely or enforce the restriction. A signed job description cannot tell us who actually took the vitals or performed the office tests.
The complaint against Labcorp alleged that it supplied referring physicians with free blood-draw and processing services. The whistleblowers valued that benefit by reference to a full-time phlebotomist’s salary and benefits. The complaint also quoted a Labcorp executive discussing a separate cash payment to physicians for draws Labcorp performed:
there could be a major compliance problem when the doctor gets 25 bucks for a draw we do.
The allegation puts both benefits in view: somebody else supplies the labor, and the physician still gets paid for the draw. We would want to understand the work allocation as closely as the payment.
The government alleged that Alpha Genomix Laboratories disguised kickbacks by paying the salary of someone who worked primarily for Aiken Counseling Group. The alleged purpose was to induce genetic-testing referrals. According to the South Carolina settlement announcement, most referrals were not legitimately ordered by a physician and were medically unnecessary. Medicare and South Carolina Medicaid paid the claims.
The September 2021 settlement called for $35,000 upfront and a percentage of gross annual revenues, up to a total of $200,000. A psychiatrist formerly employed by Aiken brought the whistleblower case.
Payroll alone would show Alpha Genomix paying an employee. The alleged kickback becomes visible when that payroll is compared with whose work the employee performed and whose tests the practice ordered. That is why the office manager’s knowledge can matter as much as the laboratory’s ledger.
Free services can take over obligations belonging to the referring facility. In its 1997 letter on free laboratory services, OIG examined a request describing nursing homes seeking free chart reviews, changes to standing orders, checks that tests and results reached patients’ charts, drug-regimen reviews and infection-control services.
OIG’s concern was the work the recipient otherwise had to provide at its own expense. If a purpose of supplying that work free was to secure federal-program referrals, the service could be a kickback. The benefit was the nursing home’s avoided expense.
Even specimen labeling can carry that benefit. In its 2016 dialysis-labeling opinion, OIG described free labeling services that would replace work dialysis facilities otherwise had to fund. The laboratory proposed offering the service when necessary to obtain or retain their business. Who normally bears the cost matters even when the task involves a specimen.
A contract’s description has to be compared with the work and the referral arrangement. Labtech Diagnostics and its founder and chief executive agreed in January 2026 to a civil settlement of at least $6.8 million over alleged referral kickbacks. The Justice Department’s civil allegations included payments described as rent, phlebotomy and toxicology services, with false square footage and hours recorded on certification forms.
The same civil settlement addressed an allegedly inflated payment for used laboratory equipment. It also addressed free drug-screening services and supplies allegedly provided to a pain practice in return for its drug-confirmation referrals. Different labels, the same alleged purchase of business. The Justice Department also reported civil recoveries from nine doctors over alleged kickbacks for Labtech referrals.
We compare the space rented, the hours worked and the equipment bought with the testing sent back. The person inside the practice can tell us whether those payments matched the work or bought the referrals.
The payer belongs in that comparison too. OIG’s laboratory payments alert says its concerns about specimen-processing payments remain when the arrangement covers only patients outside federal health care programs. Such payments can disguise compensation for federal-program business.
Precision Toxicology’s $27 million settlement in October 2024 addressed allegations of unnecessary urine drug testing and free items supplied to physicians who agreed to refer expensive testing. The government alleged that custom profiles operated as standing orders, generating large numbers of tests without an individualized assessment of need.
Its corporate integrity agreement required review of the order forms themselves. Those forms connect the relationship won by sales to the tests ordered and billed.
Genotox Laboratories supplied an admission about that ordering mechanism. In its civil settlement, Genotox admitted offering custom profiles that preselected tests for all or nearly all of a provider’s patients, generally at the highest reimbursement categories. That included definitive testing for 22 or more drug classes.
An arrangement that wins the practice’s referrals can feed a profile applied across its patients. The supply agreement explains why the specimens arrive. The requisition explains what the laboratory does with each one.
The same question about who benefits reaches equipment and software. OIG’s laboratory alert described computers and fax machines in terms of whether they served the outside laboratory’s work exclusively. It separately identified free testing for healthcare providers, their families and employees, and disposal of waste unrelated to the laboratory’s specimens.
We examine the actual functions and expenses the supplier took over.
Laboratory kickbacks become visible when the promised benefit, the employee’s actual work and the testing billed tell different stories. We connect those records with the insider who knows the arrangement.
Model Plan Helps Laboratories Fight Fraud, published in Laboratory Medicine in 1997, described standardized requisitions and physician acknowledgment of custom profiles. Its account also covered monitoring standing orders and training phlebotomists. The same people who use the forms and perform the work can see when the practice departs from the policy.
A phlebotomist may recognize duties outside the stated assignment. A practice manager may know which expense disappeared. A sales representative may know the condition attached to the offer. We work with that firsthand knowledge to understand the arrangement across the records.
A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.
If you know which cups, salary or office services were offered for referrals, speak with our whistleblower experts about the arrangement. We connect what you saw with the staffing, supply and testing records to build your strongest laboratory kickback case. We bring in laboratory fraud whistleblower lawyers who understand referral arrangements and stay beside you through the process.